The miR-134, whose expression is down-modulated in osteosarcoma tissues [176], was found to attenuate the growth and neovessel formation in osteosarcoma by targeting the VEGF-A/VEGFR-1 signaling [177]. Here, VEGFA is linked to osteosarcoma.